Episode 9
Tesamorelin Peptide: the Long-Acting GHRH Analogue
Tesamorelin is a 44-amino-acid GHRH analogue studied for sustained growth-hormone signalling. What visceral-fat and metabolic research has measured, and what is still open.
Now playing · Episode 9
Tesamorelin Peptide: the Long-Acting GHRH Analogue
Transcript
- Hi, Peppy here, and this is tesamorelin, a 44-amino acid
- peptide, the longer-acting version
- of growth hormone-releasing hormone designed for sustained
- metabolic effect.
- Here's what makes it different.
- While other GHRH peptides amplify natural pulses, tesamore
- lin holds a longer signal.
- That extended action targets one specific kind of fat in
- your body, visceral fat, the
- deep fat that wraps around your organs, drives inflammation
- , and is the hardest to lose.
- How? It binds to the GHRH receptor in your pituitary and
- sustains a steady release of growth hormone.
- That signal tells the liver to burn the visceral fat
- instead of storing it.
- Here's what people feel.
- Visible reduction in belly and waist over weeks, especially
- the deep fat you can't reach with
- diet alone.
- Better metabolic markers, including triglycerides and lipid
- profile.
- A lighter feeling in the body because the inflammatory deep
- fat is leaving instead of just water.
- And steadier energy through the day as your metabolism
- improves.
- Tesamorelin pairs naturally with ipamorelin for dual GH
- stimulation or with MOTSC for metabolic
- synergy.
- Combined with retitrutide, the three form what is known as
- the edge protocol.
- For the most aggressive triple pathway metabolic
Read the research note
Watch the film